Analysis of the Tests for New Life Extending Cancer Drugs

Journal Title: Journal of Practical Biochemistry and Biophysics - Year 2017, Vol 2, Issue 2

Abstract

Since many decades basis of research for the detection of the cancer biomarkers is opted by many researcher to identify new drug for cancer. Specific biomarker assessment for the cancer will help in the diagnostic approach for the cancer diagnosis along with the assessment of the progress of the treatment. There are many cases where the association of the cancer with specific biomarker is possible. The example for reference may be the two types of colony stimulating factors, G-CSF and M-CSF. M-CSF promotes the production and activation of Monocytes, and G-CSF stimulates the production of granulocytes from stem cells in the bone marrow. G-CSF and GM-CSF, which are produced by recombinant DNA technology, have been approved by the FDA for use in patients with bone marrow depression, such as cancer patients and patients who receive bone marrow transplants. In these patients it is observed that the bone marrow depression is usually associated with intensive chemotherapy or irradiation, and the use of colony stimulating factors avoids the profound and prolonged neutropenia as seen in controls not receiving these compounds, with a corresponding decrease in morbidity and mortality. On the other hand, administration of G-CSF or GM-CSF is expensive and can be associated with severe side effects. The deployment of the new life extending cancer drugs is needed to be measured for its efficacy. The effect of drugs may be detected through the detection of the low amount of the secondary associated biomarkers of the cancer. The various oncologists have different opinion in use of the detection of the immunogenic biomarkers with cancers.

Authors and Affiliations

Sachin C. Narwadiya

Keywords

Related Articles

Study of Hormone and Lipid Profile in Polycystic Ovarian Syndrome Women between the Age 18 to 30 Years

Background: Polycystic Ovarian Sydrome (PCOS) is an intense problem which manifiests later as infertility, obesity, insulin resistance, dyslipidemia, endothelial dysfunction & overt diabetes mellitus. PCOS is often assoc...

Study of Oxidative Stress in Smokers by Estimation of Serum Malondialdehyde Uric Acid and Bilirubin

Background: Study of Malondialdehyde Uric Acid and Bilirubin smokers provides opportunity to explain the correlation between cigarette smoking activity and oxidative stress. Cigarette smoking is the second cause of death...

Healthcare on the Path of Advancement in Technologies

Healthcare is a sector which is highly demanded and used by the public. There is scope of better diagnosis, treatment and surgeries in healthcare. The healthcare industry is spread worldwide. Medical tourism enabling cit...

Surface Plasmon Resonance Mediated Evaluation of Cartilage Oligomeric Matrix Protein in serum of Elderly Patients with Knee Osteoarthritis: An Indian Perspective

The knee osteoarthritis is the most common arthritis in elderly and diagnosed clinically and radiologically. New biomarkers are being tried to diagnose knee osteoarthritis. This work aims to explore the relationship betw...

Assessment of Obstructive and Restrictive Impairments Among of Urban Population of Jaipur: A Survey Study

The Spirometry is the test usually used to diagnose the capacity of lungs. Spirometry which signifies meant the measurement of breath. The Spirometry is routinely performed as part of the pulmonary function tests (PFTs)....

Download PDF file
  • EP ID EP470335
  • DOI -
  • Views 71
  • Downloads 0

How To Cite

Sachin C. Narwadiya (2017). Analysis of the Tests for New Life Extending Cancer Drugs. Journal of Practical Biochemistry and Biophysics, 2(2), 83-87. https://europub.co.uk/articles/-A-470335